CARRIE CADORNA: Open Payments
NPI 1013359231 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 14 payments from 10 companies in 2025. Trend: 2023 $995 · 2024 $587 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 1 | $149 |
| Dendreon Pharmaceuticals LLC | 2 | $57 |
| Antares Pharma, Inc. | 2 | $39 |
| Boston Scientific Corporation | 1 | $38 |
| Janssen Biotech, Inc. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Endo USA, Inc. | 1 | $28 |
| Calyxo, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $17 |
Products named: JELMYTO, PROVENGE, XYOSTED, General - Erectile Dysfunction, ERLEADA, XIAFLEX, CVAC ASPIRATION SYSTEM, XTANDI.
Industry payments across NE — which companies pay providers there.
